de Bruijn RE - Search Results

1

Comparison of pre-treatment MSKCC and IMDC prognostic risk models in patients with synchronous metastatic renal cell carcinoma treated in the era of targeted therapy.

Noe A, de Bruijn RE, Blank C, Horenblas S, Haanen J, Bex A. Noe A, et al. Among authors: de bruijn re. World J Urol. 2016 Aug;34(8):1067-72. doi: 10.1007/s00345-016-1769-7. Epub 2016 Feb 1. World J Urol. 2016. PMID: 26832350

2

Is there a role for neoadjuvant targeted therapy to downsize primary tumors for organ sparing strategies in renal cell carcinoma?

Bex A, Kroon BK, de Bruijn R. Bex A, et al. Int J Surg Oncol. 2012;2012:250479. doi: 10.1155/2012/250479. Epub 2012 Jun 20. Int J Surg Oncol. 2012. PMID: 22778936 Free PMC article.

3

Probability of downsizing primary tumors of renal cell carcinoma by targeted therapies is related to size at presentation.

Kroon BK, de Bruijn R, Prevoo W, Horenblas S, Powles T, Bex A. Kroon BK, et al. Urology. 2013 Jan;81(1):111-5. doi: 10.1016/j.urology.2012.09.014. Epub 2012 Nov 13. Urology. 2013. PMID: 23153934 Review.

4

Patients with penile cancer and the risk of (pre)malignant cervical lesions in female partners: a retrospective cohort analysis.

de Bruijn RE, Heideman DA, Kenter GG, van Beurden M, van Tinteren H, Horenblas S. de Bruijn RE, et al. BJU Int. 2013 Nov;112(7):905-8. doi: 10.1111/bju.12237. Epub 2013 Jul 26. BJU Int. 2013. PMID: 23905914

5

Baseline tumor volume in assessing prognosis of patients with intermediate-risk synchronous metastatic renal cell carcinoma.

de Bruijn RE, Nijkamp J, Noe A, Horenblas S, Haanen JB, Prevoo W, Bex A. de Bruijn RE, et al. Urol Oncol. 2016 Jun;34(6):258.e7-258.e13. doi: 10.1016/j.urolonc.2015.12.007. Epub 2016 Jan 25. Urol Oncol. 2016. PMID: 26822077

6

The current management of renal cell carcinoma.

Kuusk T, Grivas N, de Bruijn R, Bex A. Kuusk T, et al. Minerva Med. 2017 Aug;108(4):357-369. doi: 10.23736/S0026-4806.17.05058-3. Epub 2017 Feb 7. Minerva Med. 2017. PMID: 28176516 Review.

7

Observation After Cytoreductive Nephrectomy in Patients With Synchronous Not Completely Resected Metastases of Renal Cell Carcinoma.

de Bruijn RE, Kuusk T, Noe AP, Blank CU, Haanen JBAG, Hendricksen K, Horenblas S, Bex A. de Bruijn RE, et al. Urology. 2017 Nov;109:127-133. doi: 10.1016/j.urology.2017.06.048. Epub 2017 Aug 2. Urology. 2017. PMID: 28780300

8

Author Reply.

de Bruijn RE, Bex A. de Bruijn RE, et al. Urology. 2017 Nov;109:132-133. doi: 10.1016/j.urology.2017.06.050. Urology. 2017. PMID: 28867145 No abstract available.

9

Lymphatic Drainage from Renal Tumors In Vivo: A Prospective Sentinel Node Study Using SPECT/CT Imaging.

Kuusk T, De Bruijn R, Brouwer OR, De Jong J, Donswijk M, Grivas N, Hendricksen K, Horenblas S, Prevoo W, Valdés Olmos RA, Van Der Poel HG, Van Rhijn BWG, Wit EM, Bex A. Kuusk T, et al. J Urol. 2018 Jun;199(6):1426-1432. doi: 10.1016/j.juro.2017.11.112. Epub 2017 Dec 6. J Urol. 2018. PMID: 29223390

10

External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.

Marconi L, de Bruijn R, van Werkhoven E, Beisland C, Fife K, Heidenreich A, Kapoor A, Karam J, Kauffmann C, Klatte T, Ljungberg B, Matin S, Sjoberg D, Staehler M, Stewart GD, Tanguay S, Uzzo R, Welsh S, Wood L, Wood C, Bex A. Marconi L, et al. World J Urol. 2018 Dec;36(12):1973-1980. doi: 10.1007/s00345-018-2427-z. Epub 2018 Aug 1. World J Urol. 2018. PMID: 30069581

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters